Academic Journals Database
Disseminating quality controlled scientific knowledge

Core Evidence

ISSN: 1555--1741
Publisher: Dove Press


ADD TO MY LIST
 
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer

Author(s): Golshayan AR | Antonarakis ES
Volume: 2013
Issue: default
Year: 2013
Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia

Author(s): Chavez JC | Sahakian E | Pinilla-Ibarz J
Volume: 2013
Issue: default
Year: 2013
An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies

Author(s): Goard CA | Schimmer AD
Volume: 2013
Issue: default
Year: 2013
Lixivaptan – an evidence-based review of its clinical potential in the treatment of hyponatremia

Author(s): Bowman BT | Rosner MH
Volume: 2013
Issue: default
Year: 2013
Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis

Author(s): Botrel TEA | Clark O | Pompeo ACL | Bretas FFH | Sadi MV | Ferreira U | dos Reis RB
Volume: 2013
Issue: default
Year: 2013
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review

Author(s): Schaller SJ | Fink H
Volume: 2013
Issue: default
Year: 2013
Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation

Author(s): Lee N | Wald A
Volume: 2012
Issue: default
Year: 2012
An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy

Author(s): Watkins RR | Lemonovich TL | File Jr TM
Volume: 2012
Issue: default
Year: 2012
Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation

Author(s): McCarty EJ | Dinsmore WW
Volume: 2012
Issue: default
Year: 2012
An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II

Author(s): Floccard B | Hautin E | Bouillet L | Coppere B | Allaouchiche B
Volume: 2012
Issue: default
Year: 2012
Plerixafor for autologous CD34+ cell mobilization

Author(s): Huda Salman | Hillard M Lazarus
Volume: 2011
Issue: default
Year: 2011
Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes

Author(s): Barnett AH
Volume: 2011
Issue: default
Year: 2011
Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Author(s): Jain S | Diefenbach C | Zain J | O'Connor OA
Volume: 2011
Issue: default
Year: 2011
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis

Author(s): Eliana Krulig | Kenneth B Gordon
Volume: 2010
Issue: default
Year: 2010
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Author(s): Rossana Berardi | Azzurra Onofri | Mirco Pistelli | et al
Volume: 2010
Issue: default
Year: 2010
Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review

Author(s): Sonia Okuyama | Rene Gonzalez | Karl D Lewis
Volume: 2010
Issue: default
Year: 2010
Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease

Author(s): Markos Poulopoulos | Cheryl Waters
Volume: 2010
Issue: default
Year: 2009
Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation

Author(s): Renee M Sullivan | Brian Olshansky
Volume: 2010
Issue: default
Year: 2010
Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Author(s): Kristen Kulasa | Steven Edelman
Volume: 2010
Issue: default
Year: 2010
Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

Author(s): Elias Jabbour | Jorge Cortes | Hagop Kantarjian
Volume: 2009
Issue: default
Year: 2009
Raltegravir: The evidence of its therapeutic value in HIV-1 infection

Author(s): Kavya Ramkumar | Nouri Neamati
Volume: 2009
Issue: default
Year: 2009
Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection

Author(s): Hans-Jürgen Stellbrink
Volume: 2009
Issue: default
Year: 2009
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas

Author(s): Ayman I Omar | Warren P Mason
Volume: 2009
Issue: default
Year: 2009
Conivaptan: Evidence supporting its therapeutic use in hyponatremia

Author(s): Melissa Li-Ng | Joseph G Verbalis
Volume: 2009
Issue: default
Year: 2009
Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy

Author(s): Daniel Z Lieberman | Suena H Massey
Volume: 2009
Issue: default
Year: 2009
Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist

Author(s): Kai M Beeh | Jutta Beier
Volume: 2009
Issue: default
Year: 2009
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

Author(s): Paul Richardson | Constantine Mitsiades | Jacob Laubach | et al
Volume: 2009
Issue: default
Year: 2009
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation

Author(s): Peter Deibert | Carola Xander | Hubert E Blum | et al
Volume: 2009
Issue: default
Year: 2009
Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis

Author(s): Stephen T Sonis
Volume: 2009
Issue: default
Year: 2009
Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Author(s): Hari A Deshpande, Scott Gettinger | Julie Ann Sosa
Volume: 2009
Issue: default
Year: 2009
Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact

Author(s): Jean-Marie Krzesinski | Eric P Cohen
Volume: 2009
Issue: default
Year: 2009
Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis

Author(s): Troels Herlin
Volume: 2009
Issue: default
Year: 2009
Eptifibatide: The evidence for its role in the management of acute coronary syndromes

Author(s): Ibrahim Shah | Shakeel O Khan | Surender Malhotra | Tim Fischell
Volume: 2009
Issue: default
Year: 2009
Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect

Author(s): E Michael Lewiecki
Volume: 2009
Issue: default
Year: 2009
Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

Author(s): Angelo L Gaffo | Kenneth G Saag
Volume: 2009
Issue: default
Year: 2009
Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma

Author(s): Katherine A Thornton
Volume: 2009
Issue: default
Year: 2009
Lasofoxifene: Evidence of its therapeutic value in osteoporosis

Author(s): Luigi Gennari | Daniela Merlotti | Vincenzo De Paola | Ranuccio Nuti
Volume: 2009
Issue: default
Year: 2009
Agomelatine: The evidence for its place in the treatment of depression

Author(s): Daniela Eser | Thomas C Baghai | Hans-Jürgen Möller
Volume: 2009
Issue: default
Year: 2009
Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Author(s): Louise Profit | Paul Chrisp | Carole Nadin
Volume: 2008
Issue: Issue 1
Year: 2008
Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome

Author(s): Arash Aghel | W. H. Wilson Tang
Volume: 2008
Issue: Issue 1
Year: 2008
Omalizumab: the evidence for its place in the treatment of allergic asthma

Author(s): Diarmuid M. McNicholl | Liam G. Heaney
Volume: 2008
Issue: Issue 1
Year: 2008
RPA Switzerland

RPA Switzerland

Robotic process automation

    

Tango Jona
Tangokurs Rapperswil-Jona